Cognitive impairment is a common comorbidity in COVID-19 deceased patients. A hospital-based retrospective cohort study
Paloma Martín-Jiménez, Mariana I. Muñoz-García, David Seoane, Lucas Roca-Rodríguez, Ana García-Reyne, Antonio Lalueza, Guillermo Maestro, Dolores Folgueira, Víctor A. Blanco-Palmero, Alejandro Herrero-San Martín, Sara Llamas-Velasco, David A. Pérez-Martínez, Marta González-Sánchez, Alberto Villarejo-Galende
doi: https://doi.org/10.1101/2020.06.08.20125872
Paloma Martín-Jiménez
1Department of Neurology. Hospital Universitario 12 de Octubre. Madrid. Spain
Mariana I. Muñoz-García
1Department of Neurology. Hospital Universitario 12 de Octubre. Madrid. Spain
David Seoane
1Department of Neurology. Hospital Universitario 12 de Octubre. Madrid. Spain
Lucas Roca-Rodríguez
1Department of Neurology. Hospital Universitario 12 de Octubre. Madrid. Spain
Ana García-Reyne
2Department of Internal Medicine. Hospital Universitario 12 de Octubre. Madrid. Spain
Antonio Lalueza
2Department of Internal Medicine. Hospital Universitario 12 de Octubre. Madrid. Spain
3Department of Medicine. School of Medicine, Complutense University, Madrid, Spain
5Group of Neurodegenerative Diseases, Instituto de Investigación Hospital 12 de Octubre (I+12). Madrid, Spain
Guillermo Maestro
2Department of Internal Medicine. Hospital Universitario 12 de Octubre. Madrid. Spain
Dolores Folgueira
3Department of Medicine. School of Medicine, Complutense University, Madrid, Spain
4Department of Microbiology. Hospital Universitario 12 de Octubre. Madrid. Spain
Víctor A. Blanco-Palmero
1Department of Neurology. Hospital Universitario 12 de Octubre. Madrid. Spain
5Group of Neurodegenerative Diseases, Instituto de Investigación Hospital 12 de Octubre (I+12). Madrid, Spain
6Biomedical Research Networking Center in Neurodegenerative diseases (CIBERNED), Madrid, Spain
Alejandro Herrero-San Martín
1Department of Neurology. Hospital Universitario 12 de Octubre. Madrid. Spain
5Group of Neurodegenerative Diseases, Instituto de Investigación Hospital 12 de Octubre (I+12). Madrid, Spain
6Biomedical Research Networking Center in Neurodegenerative diseases (CIBERNED), Madrid, Spain
Sara Llamas-Velasco
1Department of Neurology. Hospital Universitario 12 de Octubre. Madrid. Spain
5Group of Neurodegenerative Diseases, Instituto de Investigación Hospital 12 de Octubre (I+12). Madrid, Spain
6Biomedical Research Networking Center in Neurodegenerative diseases (CIBERNED), Madrid, Spain
David A. Pérez-Martínez
1Department of Neurology. Hospital Universitario 12 de Octubre. Madrid. Spain
3Department of Medicine. School of Medicine, Complutense University, Madrid, Spain
5Group of Neurodegenerative Diseases, Instituto de Investigación Hospital 12 de Octubre (I+12). Madrid, Spain
6Biomedical Research Networking Center in Neurodegenerative diseases (CIBERNED), Madrid, Spain
Marta González-Sánchez
1Department of Neurology. Hospital Universitario 12 de Octubre. Madrid. Spain
5Group of Neurodegenerative Diseases, Instituto de Investigación Hospital 12 de Octubre (I+12). Madrid, Spain
6Biomedical Research Networking Center in Neurodegenerative diseases (CIBERNED), Madrid, Spain
Alberto Villarejo-Galende
1Department of Neurology. Hospital Universitario 12 de Octubre. Madrid. Spain
3Department of Medicine. School of Medicine, Complutense University, Madrid, Spain
5Group of Neurodegenerative Diseases, Instituto de Investigación Hospital 12 de Octubre (I+12). Madrid, Spain
6Biomedical Research Networking Center in Neurodegenerative diseases (CIBERNED), Madrid, Spain
Data Availability
Anonymized data may be available upon reasonable request from qualified researchers.
Posted June 09, 2020.
Cognitive impairment is a common comorbidity in COVID-19 deceased patients. A hospital-based retrospective cohort study
Paloma Martín-Jiménez, Mariana I. Muñoz-García, David Seoane, Lucas Roca-Rodríguez, Ana García-Reyne, Antonio Lalueza, Guillermo Maestro, Dolores Folgueira, Víctor A. Blanco-Palmero, Alejandro Herrero-San Martín, Sara Llamas-Velasco, David A. Pérez-Martínez, Marta González-Sánchez, Alberto Villarejo-Galende
medRxiv 2020.06.08.20125872; doi: https://doi.org/10.1101/2020.06.08.20125872
Cognitive impairment is a common comorbidity in COVID-19 deceased patients. A hospital-based retrospective cohort study
Paloma Martín-Jiménez, Mariana I. Muñoz-García, David Seoane, Lucas Roca-Rodríguez, Ana García-Reyne, Antonio Lalueza, Guillermo Maestro, Dolores Folgueira, Víctor A. Blanco-Palmero, Alejandro Herrero-San Martín, Sara Llamas-Velasco, David A. Pérez-Martínez, Marta González-Sánchez, Alberto Villarejo-Galende
medRxiv 2020.06.08.20125872; doi: https://doi.org/10.1101/2020.06.08.20125872
Subject Area
Subject Areas
- Addiction Medicine (353)
- Allergy and Immunology (675)
- Anesthesia (182)
- Cardiovascular Medicine (2675)
- Dermatology (226)
- Emergency Medicine (404)
- Epidemiology (12292)
- Forensic Medicine (10)
- Gastroenterology (768)
- Genetic and Genomic Medicine (4144)
- Geriatric Medicine (388)
- Health Economics (682)
- Health Informatics (2685)
- Health Policy (1008)
- Hematology (365)
- HIV/AIDS (857)
- Medical Education (401)
- Medical Ethics (110)
- Nephrology (443)
- Neurology (3926)
- Nursing (212)
- Nutrition (584)
- Oncology (2064)
- Ophthalmology (592)
- Orthopedics (243)
- Otolaryngology (306)
- Pain Medicine (251)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1126)
- Primary Care Research (461)
- Public and Global Health (6566)
- Radiology and Imaging (1415)
- Respiratory Medicine (874)
- Rheumatology (413)
- Sports Medicine (344)
- Surgery (454)
- Toxicology (54)
- Transplantation (189)
- Urology (169)